Spain· ES:18221
BUSCAPINA 10 mg COMPRIMIDOS RECUBIERTOS
A medicinal product containing butilescopolamina bromuro, registered in Spain by Opella Healthcare Spain S.L..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- butilescopolamina bromuro
- Manufacturer
- Opella Healthcare Spain S.L.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo65675060EUR 6.12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e85fdd1c-64ec-411b-aa19-87f465738724 GET /v1/drugs/e85fdd1c-64ec-411b-aa19-87f465738724?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Sin Receta",
"estado": "{\"aut\":-541731600000}",
"nregistro": "18221",
"substance": "butilescopolamina bromuro"
}See everything about butilescopolamina bromuro.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.